期刊文献+

2,3,5-三-O-苄基-1-O-对硝基苯甲酰基-D-阿拉伯呋喃糖的合成 被引量:1

Synthesis of 2,3,5-tri-O-Benzyl-1-O-(p-nitrobenzoyl)-D-arabinofuranose
下载PDF
导出
摘要 D-阿拉伯糖经甲基化、苄基化得1-O-甲基-2,3,5-三-O-苄基-D-阿拉伯呋喃糖,再经水解、由对硝基苯甲酰氯酰化制得核苷类药物中间体2,3,5-三-O-苄基-1-O-对硝基苯甲酰基-D-阿拉伯呋喃糖,总收率约45%。 2,3,5-tri-O-Benzyl-1-O-(p-nitrobenzoyl)-D-arabinofuranose was synthesized from D-arabinose by methylation and benzylation to give 1-O-methyl-2,3,5-tri-O-benzyl-D-arabinofuranose, which was subjected to hydrolysis and acylation with an overall yield of about 45 %.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2007年第12期834-835,共2页 Chinese Journal of Pharmaceuticals
关键词 2 3 5-三-O-苄基-1-O-对硝基苯甲酰基-D-阿拉伯呋喃糖 中间体 合成 2,3,5-tri-O-benzyl-1-O-(p-nitrobenzoyl)-D-arabinofuranose intermediate synthesis
  • 相关文献

参考文献5

  • 1Montgomery JA, Clayton SD, Shortnacy AT. An improved procedure for the preparation of 9-β-D-arabinofuranosyl-2- fluoroadenine [J]. J Heterocycl Chem, 1979, 16 (1) : 157-160.
  • 2Glaudemans CPJ, Fletcher HG Jr. Syntheses with partially benzylated Sugar. Ⅲ. A simple pathway to a "cis-nucleoside," 9-β-D-arabinofuranosyladenine (spongoadenosine) [J]. J Org Chem, 1963, 28 (11) : 3004-3006.
  • 3Tejimo S, Fletcher HG Jr. Syntheses with partially benzylated sugars. Ⅱ. The anomeric 1-O-benzoyl-L-arabinopyranoses and 1-O-benzoyl-L-arabinofuranoses and their tendencies to undergo acyl migration[J]. J Org Chem, 1963, 28(11): 2999-3004.
  • 4Barker R, Fletcher HG Jr. 2,3,5-tri-O-Benzyl-D-ribosyl and -L-arabinosyl bromides[J]. J Org Chem, 1961, 26(11): 4605-4609.
  • 5van der Klein PAM, de Nooya E J, van der Marel GA, et al. Synthesis of 2,3,5-tri-O-benzyl-D-arabinitol 1,4-cyclic sulfate and its conversion into potential precursors of shikimate substrate analogues[J]. Synthesis, 1991, (5) : 347-349.

同被引文献10

  • 1朱翊,傅得兴.T细胞选择性核苷类似物奈拉滨[J].中国新药杂志,2007,16(3):252-255. 被引量:6
  • 2Evanswe P. Acute lymphoblastic leukemia [J]. N Engl J Med, 1998, 339 (9): 605-615.
  • 3Parkerwb, Secristja, Waudwr, et al. Purine nucleoside analogues in development for the treatment of cancer [J]. Curropin Investing Drugs, 2004, 5 (6): 592-596.
  • 4Kisordf, Plunkettw, Kurtzberg. Pharmacokinetics of nelarabine and 9-beta-D-arabinofuranosyl guanine in pediatric and aduhpatientsduring a phase I study ofnelarabine for the treatmentof refractory hematologicmalignancies[J]. J Clin Oncol, 2000, 18 (5): 995-1 003.
  • 5Gandhiv, Keating M J, Bate G. Nelarabine [J]. Nat Rev Drug Discov, 2006, 5 (1): 17-18.
  • 6Krenitsky T A, Hill C, Raleigh, et al.Tumor treatment with arabinofuranosyl purine derivatives [P]. US: 5 821 236, 1998- 10-23.
  • 7Krenitsky T A, Walter K G, Addington J L Y, et al. Antiviral compounds[P]. EP: 0 294 114, 2007-12-08.
  • 8顾群,孙学伟,徐春霞.一种奈拉滨的合成方法[P].CN:101092441A,2007-12-16.
  • 9尤启东,林国强.手性药物-研究与应用[M].北京:化学工业出版社.2004.597-598.
  • 10朱尔佳,梁可,张浩,曹蕾,谭载友.治疗T-淋巴细胞白血病新药——奈拉滨(Nelarabine)的研究进展[J].中国处方药,2007,6(12):74-75. 被引量:3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部